Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
US9346805B2 · kind B2 · utility
0Cited by
4References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2012 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Jul 1, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I including tautomers, resolved enantiomers, resolved diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.Also provided are methods of using the compounds of this invention as Akt protein kinase inhibitors and for the treatment of Akt-mediated diseases, for example, hyperproliferative diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.